Bifunctional small molecules targeting PD-L1/CXCL12 as dual immunotherapy for cancer treatment

• Binbin Cheng,
• Wei Wang,
• Ting Liu,
• Hao Cao,
• Wei Pan,
• Yao Xiao,
• Shuwen Liu,
• Jianjun Chen

Affiliations

Binbin Cheng

School of Medicine, Hubei Polytechnic University, Hubei Key Laboratory for Kidney Disease Pathogenesis and Intervention

Wei Wang

School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University

Ting Liu

School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University

Hao Cao

School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University

Wei Pan

Department of Cardiology, The Sixth Affiliated Hospital, South China University of Technology, Nanhai people’s Hospital, Foshan

Yao Xiao

School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University

Shuwen Liu

School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University

Jianjun Chen

School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University